SynthesisJournal of the American College of Cardiology2023
P2Y
Open access · greenAbstract readMeta-Analysis
In one paragraph
Synthesis in Journal of the American College of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
24.1field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 110 citations in OpenAlex.
- P2YJournal of the American Heart Association · 2025Pooled it
- P2Y12 inhibitor monotherapy after complex percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.Scientific reports · 2023Pooled it
- Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial.European heart journal. Cardiovascular pharmacotherapy · 2025Trial
- Article
- Early Aspirin Discontinuation Following PCI for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of Reconstructed Individual Patient Data.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Review
- Antiplatelet Therapy in Patients Receiving Percutaneous Coronary Intervention for Bifurcation Lesions.Korean circulation journal · 2026Review
- Antithrombotic Strategies After Complex Percutaneous Coronary Intervention.Journal of clinical medicine · 2026Review
- Two-Year Clinical Outcomes in Patients With Coronary Bifurcation Lesions: Results From the Onyx ONE Clear Study.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
- Duration of dual antiplatelet therapy and risk of stent thrombosis in patients undergoing complex PCI: a meta-analysis.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Article
- Ticagrelor Resistance Causing Acute In-Stent Thrombosis: Successful Management With Prasugrel and Balloon Angioplasty.Journal of medical cases · 2026Article
- Clinical validation study of a novel prognostic risk prediction model (CHIP Score) for interventional therapy in patients with NSTE-ACS-a single-center retrospective cohort study based on 348 patients.BMC cardiovascular disorders · 2026Article
- Comparative Evaluation of Prolonged Dual Antiplatelet Therapy versus Conventional Regimens on Prognosis in Patients with High Residual Inflammatory Risk: Results from a Prospective Observational Study.Journal of inflammation research · 2026Article
- Antithrombotic therapy in complex percutaneous coronary intervention.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025Review
- P2YReviews in cardiovascular medicine · 2025Article
- Comparison of Valve Academic Research Consortium (VARC)-2 and VARC-3 Criteria for Bleeding Complications After Transcatheter Aortic Valve Replacement.Journal of the American Heart Association · 2025Article
- Reassessing single-stent techniques for isolated left anterior descending ostial disease: a two-year intravascular ultrasound-guided retrospective comparison of precise ostial, floating, and crossover stenting strategies.BMC cardiovascular disorders · 2025Article
- Bleeding Complications of Anticoagulation Therapy Used in the Treatment of Acute Coronary Syndromes-Review of the Literature.Journal of clinical medicine · 2025Review
- Impact of procedural and patient-related risks on 1-year outcomes for patients treated with 1-month dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy after biodegradable-polymer drug-eluting stent implantation.Cardiovascular intervention and therapeutics · 2025Article
- Phenotyping the Use of Cangrelor in Percutaneous Coronary Interventions.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Pharmacovigilance analysis of small bowel bleeding associated with NSAIDs.Therapeutic advances in drug safety · 2025Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
28 authors at 17 institutions in 10 countries.
Felice GragnanoDepartment of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Caserta, Italy.
Roxana MehranIcahn School of Medicine at Mount Sinai, New York, New York, USA.
Mattia BrancaClinical Trials Unit, Bern, Switzerland.
Anna FranzoneDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Usman BaberUniversity of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Yangsoo JangDepartment of Cardiology, CHA Bundang Medical Center, CHA University College of Medicine, Seongnam, South Korea.
Takeshi KimuraKyoto University Graduate School of Medicine, Department of Cardiovascular Medicine, Kyoto, Japan.
Joo-Yong HahnHeart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Qiang ZhaoDepartment of Cardiovascular Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Stephan WindeckerDepartment of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
Charles M GibsonDivision of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Byeong-Keuk KimDepartment of Cardiology, CHA Bundang Medical Center, CHA University College of Medicine, Seongnam, South Korea.
Hirotoshi WatanabeKyoto University Graduate School of Medicine, Department of Cardiovascular Medicine, Kyoto, Japan.
Young Bin SongHeart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Yunpeng ZhuDepartment of Cardiovascular Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pascal VranckxDepartment of Cardiology and Critical Care Medicine, Hartcentrum Hasselt, Jessa Ziekenhuis, Belgium; Faculty of Medicine and Life Sciences, University of Hasselt, Hasselt, Belgium.
Shamir MehtaDepartment of Medicine, McMaster University, Hamilton, Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada.
Sung-Jin HongDepartment of Cardiology, CHA Bundang Medical Center, CHA University College of Medicine, Seongnam, South Korea.
Kenji AndoKokura Memorial Hospital, Department of Cardiology, Kitakyushu, Japan.
Hyeon-Cheol GwonHeart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Paolo CalabròDepartment of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Caserta, Italy.
Patrick W SerruysDepartment of Cardiology, National University of Ireland Galway, Galway, Ireland; NHLI, Imperial College London, London, United Kingdom.
George D DangasIcahn School of Medicine at Mount Sinai, New York, New York, USA.
Eùgene P McFaddenCardialysis Core Laboratories and Clinical Trial Management, Rotterdam, the Netherlands; Department of Cardiology, Cork University Hospital, Cork, Ireland.
Dominick J AngiolilloDivision of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, USA.
Dik HegClinical Trials Unit, Bern, Switzerland.
Marco ValgimigliDepartment of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland; Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland. Electronic address: marco.valgimigli@eoc.ch.
Single Versus Dual Antiplatelet Therapy (Sidney-2) Collaboration
CHA University Bundang Medical Center · KRSamsung Medical Center · KRIcahn School of Medicine at Mount Sinai · USKyoto University · JPShanghai Jiao Tong University · CNUniversity of Campania "Luigi Vanvitelli" · ITBeth Israel Deaconess Medical Center · USCork University Hospital · IEEnte Ospedaliero Cantonale · CHHamilton Health Sciences · CAJessa Hospital · BEKokura Memorial Hospital · JPOllscoil na Gaillimhe – University of Galway · IEUniversity of Bern · CHUniversity of Florida · USUniversity of Naples Federico II · ITUniversity of Oklahoma Health Sciences Center · US
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIt remains unclear whether P2Y
objectivesWe sought to assess the effects of P2Y
methodsWe pooled patient-level data from randomized controlled trials comparing P2Y
resultsOf 22,941 patients undergoing PCI from 5 trials, 4,685 (20.4%) with complex PCI had higher rates of ischemic events. The primary efficacy endpoint was similar between P2Y
conclusionsP2Y
Indexed as
Percutaneous Coronary InterventionPlatelet Aggregation InhibitorsAspirinDrug Therapy, CombinationDual Anti-Platelet TherapyHemorrhageHumansPurinergic P2Y Receptor AntagonistsTreatment OutcomeAspirinPlatelet Aggregation InhibitorsPurinergic P2Y Receptor Antagonistscomplex PCIDAPTmeta-analysisP2Y(12) inhibitorspercutaneous coronary intervention
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.